Michael Kauffman - Net Worth and Insider Trading
Michael Kauffman Net Worth
The estimated net worth of Michael Kauffman is at least $970,296 dollars as of 2024-12-27. Michael Kauffman is the Director of Karyopharm Therapeutics Inc and owns about 1,603,340 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $962,004. Michael Kauffman is the Director of Adicet Bio Inc and owns about 5,900 shares of Adicet Bio Inc (ACET) stock worth over $5,664. Michael Kauffman is also the Director of Verastem Inc and owns about 667 shares of Verastem Inc (VSTM) stock worth over $2,628. Details can be seen in Michael Kauffman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Kauffman has not made any transactions after 2024-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Kauffman
Michael Kauffman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Kauffman owns 6 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Kezar Life Sciences Inc (KZR) , and Verastem Inc (VSTM) among others .
Click here to see the complete history of Michael Kauffman’s form 4 insider trades.
Insider Ownership Summary of Michael Kauffman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2022-02-17 | director & President & C.E.O. & C.M.O. |
| KZR | Kezar Life Sciences Inc | 2018-06-20 | director |
| VSTM | Verastem Inc | 2018-09-28 | director |
 | | 2017-04-05 | director |
| | 2013-06-06 | director |
| | 2024-06-05 | director |
Michael Kauffman Latest Holdings Summary
Michael Kauffman currently owns a total of 3 stocks. Among these stocks, Michael Kauffman owns 1,603,340 shares of Karyopharm Therapeutics Inc (KPTI) as of February 17, 2022, with a value of $962,004 and a weighting of 99.15%. Michael Kauffman owns 5,900 shares of Adicet Bio Inc (ACET) as of June 5, 2024, with a value of $5,664 and a weighting of 0.58%. Michael Kauffman also owns 667 shares of Verastem Inc (VSTM) as of September 28, 2018, with a value of $2,628 and a weighting of 0.27%.
Latest Holdings of Michael Kauffman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2022-02-17 | 1,603,340 | 0.60 | 962,004 |
| ACET | Adicet Bio Inc | 2024-06-05 | 5,900 | 0.96 | 5,664 |
| VSTM | Verastem Inc | 2018-09-28 | 667 | 3.94 | 2,628 |
Holding Weightings of Michael Kauffman
Michael Kauffman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Kauffman has made a total of 19 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 18,167 shares on February 17, 2022, which brought Michael Kauffman around $220,184.
According to the SEC Form 4 filings, Michael Kauffman has made a total of 1 transactions in Adicet Bio Inc (ACET) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Adicet Bio Inc is the sale of 5,900 shares on June 5, 2024, which brought Michael Kauffman around $8,437.
According to the SEC Form 4 filings, Michael Kauffman has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 333 shares on September 28, 2018, which cost Michael Kauffman around $29,960.
Insider Trading History of Michael Kauffman
- 1
Michael Kauffman Trading Performance
GuruFocus tracks the stock performance after each of Michael Kauffman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Kauffman is -51.59%. GuruFocus also compares Michael Kauffman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Kauffman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Kauffman's insider trading performs compared to the benchmark.
Performance of Michael Kauffman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -29.52 | | | | | |
| Relative Return to S&P 500(%) | -20.76 | | | | | |
Michael Kauffman Ownership Network
Michael Kauffman Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Michael Kauffman is the director & President & C.E.O. & C.M.O. of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Michael Kauffman made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,766 shares made by Richard A. Paulson , a net sale of 55,214 shares made by Michael Mason , and a net sale of 34,041 shares made by Stuart Poulton .
In summary, during the past 3 months, insiders sold 10,902 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 10,902 shares. During the past 18 months, 2,075,796 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,034,656 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Michael Kauffman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Kauffman. You might contact Michael Kauffman via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
